Slide 1: Health and Protection
flea ith Protection a ee
Slide 2: Cautionary statements
Cautionary statements This document should be read in conjunction with the documents distributed by Aviva plc (the ‘Company’ or ‘Aviva’) through The Regulatory News Service (RNS). This announcement contains, and we may make other verbal or written ‘forward-looking, statements’ with respect to certai
Slide 3: Welcome and introduction
Welcome and introduction Jason Windsor - Group CFO Health and Protection Doug Brown - CEO of UK & Ireland Life Insurance Q&A
Slide 4: Today's session
Today’s session 1 Overview of Health & Protection 2 Deep-dive into Health 3 Deep-dive into Protection MIAVIVA 4
Slide 5: Key messages
Key messages Key market and capital generative business for Aviva UK&l Life, generating c.£170m in value of new business (VNB) and c.£190m operating profit. We are the only scale UK player with #2/3 market positions serving all Health & Protection customer needs. We serve 4.5m individual customers a
Slide 6: UK&I Life and Health & Protection at a glance
UK&I Life and Health & Protection at a glance Critical part of Aviva Group £1.9bn Group UK&l Life operating profit 2020* Of which: 10% Health & Protection £1.0bn UK&l Life *From continuing operations; All footnotes on page 29 Go-to customer brand 11.5m customers looked after by our UK and Ireland Li
Slide 7: The only scale UK player serving all H&P customer needs
The only scale UK player serving all H&P customer needs Serving all customer Health & Protection needs Leveraging strengths of Aviva to compete with market leading positions Individual Group Aviva brand #1 #10 protection _Pratectron «alt Hie Eenteraion I MUAWIVAl) Aviva Position #2 #2 #3 ; 15m 4.5m
Slide 8: Leading customer proposition centred on wellbeing
Leading customer proposition centred on wellbeing Life | Income Protection | Critical Illness | Wellbeing Wellbeing central to our customer proposition 4.3m — +77 state RC Customers Claims TNPS Best Protection SS xo" Provider Ny xe ) = e Private Medical Insurance £< Private Medical Trusts | Wellbein
Slide 9: Bringing One Aviva to customers with tangible benefits
Bringing One Aviva to customers with tangible benefits Building deep relationships with employers and intermediaries and supporting multi-scheme wins Corporate & SME customers, EBCs & brokers Group Income Employee Boraplace Insurance Protection and PrivateiMedical Life Assurance Care m?a 1 | Active
Slide 10: Providing support in times of need and through Covid-19
Providing support in times of need and through Covid-19 Outstanding claims support and service Providing support through Covid-19 Launched Covid-19 Work Support Service to help rebuild mental and physical fitness of employees recovering from long-Covid via Aviva's rehabilitation consultants Provided
Slide 11: Health
Aviva: Public
Slide 12: Expecting market growth to accelerate...
Expecting market growth to accelerate... Market size: & growth c.£5bn UK private medical cover market Customer mix Consumer SME & Corporate 3% p.a. Market growth outlook All footnotes on page 29 Distribution mix: Consumer Intermediated Direct SME & Corporate Intermediated Direct Rising medical costs
Slide 13: ... Driven by fundamental market trends
... Driven by fundamental ma NHS constraints Near-term capacity constraint-waiting list of 5.6m people’ Ageing population increasing demands on health system NHS provider sector in deficit since 2013-14” Growing role of employers Growing demand for whole of workforce offerings for affordable private
Slide 14: Aviva's top position supported by leading capabilities
Aviva’s top 3 position supported by leading capabilities Aviva is a top 3 player with capacity to grow market share Market share (by PMI GWP)! Top 5 players account for 95% of market AM occo0e 12% AVIVA ty \XPA All footnotes on page 29 With leading capabilities Service +49 customer TNPS Health Insur
Slide 15: Three strategic priorities to accelerate profit growth
Three strategic priorities to accelerate profit growth @ @) @) Focus on growing in Value-based Innovation and Consumer and SME healthcare digital
Slide 16: Enhancing margin by growing in Consumer, SME & Direct
Enhancing margin by growing in Consumer, SME & Direct 5-year ambition 46% — >50% Consumer & SME Consumer & SME 15% 525% Direct Direct 85% <75% Intermediated Intermediated Key drivers for growth a — a Consumer SME Large corporate . i vit: A ye ai scticati . a a one Personalised pricing within custome
Slide 17: Our value-based healthcare proposition
Our value-based healthcare proposition = Better clinical = Contain cost outcomes inflation = Quick = Reduce cost healthcare variation access " Give financial = Expert certainty Select = Cut customer effort = Keep informed = Quick bill settlement Better value for our customers & Aviva c. 5% +100% Est
Slide 18: Engaging customers through innovation and digital
Engaging customers through innovation and digital Aviva Digital GP Aviva Digital GP Free, around the clock access to video consultations with NHS registered GPs Video modules to increase awareness of employee mental wellbeing e Line manager toolkit MyHealthCounts e@ An online health risk assessment
Slide 19: Protection
Aviva: Public
Slide 20: Growing and resilient Protection market
Growing and resilient Protection market Market size & growth Group Protection CAGR UK in-force premiums, £bn! 17-20 2.2 2.3 2.5 2.7 2017-718 19 20 Individual Protection CAGR UK new business APE, £m2 17-19 761 775 819 752 2017-18 19 20 +8% 2021 H1 YoY growth All footnotes on page 29 Market mix Group
Slide 21: Fundamental trends driving the Protection market
Fundamental trends driving the Protection market a a y . ! Protection gap and growing workplace Focus on wellbeing duty of care Holistic focus - incl. physical, mental and financial >£2tr UK protection gap’ Heightened awareness - 1 in 4 people in England will Only 47% adults taking up protection pro
Slide 22: Well positioned across Individual and Group Protection
Well positioned across Individual and Group Protection Top 2 position in both markets 2020 Market share Group Protection (by in-force premiums) #1 18% AVIVA #3 #4 #5 Individual Protection (by new business APE) #1 15%" AVIVA #3 #4 45 Charts not to scale; All footnotes on page 29 Market leading capabi
Slide 23: Three strategic priorities to accelerate profitable growth
Three strategic priorities to accelerate profitable growth @) @) @) Extending customer Digitally-led and Customer centric and distribution easy to do business innovation and reach with wellness
Slide 24: Extending customer and distribution reach
Extending customer and distribution reach ee Group Protection Individual Protection 2020 Market share (by in-force premiums) 2020 5-year ambition 10% Se =i >20% TotalAVIVA 18% NB APE » : Intermediate NB APE | mix non advised h 7 mix inc. price small 15% r Focused z 15», compason sites Spr & and tele
Slide 25: Digitally-led and easy to do business with
Digitally-led and easy to do business with Working towards seamless customer experience... ... through digitisation & automation... ... and leveraging data & machine learning All footnotes on page 29 Group Protection 70% Automation’ 70% Adoption rates so End-to-end digital journeys for SMEs uw am. D
Slide 26: Differentiating proposition through innovation
Differentiating proposition through innovation & Lifestyle nnual health check Nutrit + Gym disec + We Treatment & GP GP or Nurse helpline + Second medical opinion + Mental Health Support Eligible users Value added services / innovative provider Users likely Mental health appointments to recommend of
Slide 27: Key takeaways
Key takeaways Key market and capital generative business for Aviva UK&l Life, generating c.£170m in value of new business (VNB) and c.£190m operating profit. We are the only scale UK player with #2/3 market positions serving all Health & Protection customer needs. We serve 4.5m individual customers
Slide 28: Q&A session
Q&A session Doug Brown CEO of UK & Ireland Life Insurance IN v 2 Jason Windsor Group CFO v MAVIVA 28
Slide 29: Footnotes
Footnotes Slide Footnote ‘Sum of lives covered by Group Health and Group Protection schemes which could include some duplicate lives CAGR based on FY 2020 Limited participation in Health market. Diagnostic only, "whole of workforce’ type offer Includes multiple products on asingle policy eg, multipl